Exploring GLP-1 Receptor Agonists for Neurodegeneration - Part 2
Release Date: 02/28/2025
Sleep Apnea and Stroke Risk
Neurology Minute
Dr. Alberto Ramos discusses how managing risk factors for sleep apnea can significantly reduce systemic vascular risks and preserve neurologic function.
info_outline
Association of Migraine Treatments with Reduced Ischemic Stroke Risk
Neurology Minute
Dr. Tesha Monteith discusses the Headache Journal article, “Association of Migraine Treatments with Reduced Ischemic Stroke Risk: Evidence from Two Large-Scale Real-World Data Analyses.” Show reference:
info_outline
Investigating Whether Dissemination in Time Is Essential to Diagnose Relapsing MS
Neurology Minute
Dr. Alison Christy and Dr. Wallace J. Brownlee discuss whether dissemination in time is necessary to make a diagnosis of MS in patients who fulfill a high number of dissemination in space criteria. Show reference:
info_outline
Overview from the 2025 International Stroke Conference - Part 2
Neurology Minute
In part two of this two-part series, Dr. Andy Southerland and Dr. Seemant Chaturvedi discuss the PRESTIAGE-AF trial. Show references:
info_outline
Overview from the 2025 International Stroke Conference - Part 1
Neurology Minute
In part one of this two-part series, Dr. Andy Southerland and Dr. Seemant Chaturvedi discuss two trials that were looking at the use of endovascular therapy for medium vessel occlusion. Show references:
info_outline
Acquired Dystonia
Neurology Minute
Dr. Jeff Ratliff delves into the common causes of acquired dystonia and highlights evidence-based treatment strategies for effective management.
info_outline
Orthostatic Tremor
Neurology Minute
Dr. Jeff Ratliff provides an in-depth look at orthostatic tremor, a rare and often overlooked movement disorder, highlighting its symptoms, challenges, and the importance of early detection. Show references:
info_outline
Exploring GLP-1 Receptor Agonists for Neurodegeneration - Part 2
Neurology Minute
In part two of this two-part series, Dr. Vikram Karnik and Dr. Lorraine Kalia discuss the preclinical data and epidemiological data that led us to the phase three study on exenatide. Show reference:
info_outline
Exploring GLP-1 Receptor Agonists for Neurodegeneration - Part 1
Neurology Minute
In part one of this two-part series, Dr. Vikram Karnik and Dr. Lorraine Kalia discuss recent clinical trials on exenatide as a disease-modifying therapy for Parkinson disease. Show reference:
info_outline
Vascular Risk Factor Burden Among Young Adults with Ischemic Stroke
Neurology Minute
Dr. BJ Hicks and Dr. Aaron Shoskes discuss the rising incidence of ischemic stroke in young adults. Show references:
info_outlineIn part two of this two-part series, Dr. Vikram Karnik and Dr. Lorraine Kalia discuss the preclinical data and epidemiological data that led us to the phase three study on exenatide.
Show reference:
https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)00161-8/abstract